Jubilant LifeScience informs about updates

21 Oct 2019 Evaluate

Jubilant LifeScience has informed that material wholly-owned subsidiary, Jubilant Pharma (JPL) has given notice to the holders of its $300,000,000 4.875% Senior Notes due 2021 (the Notes) that it has elected to exercise its option to redeem $100,000,000 in aggregate principal amount of the Notes on November 20, 2019 (the Redemption Date) pursuant to the terms of the indenture dated as of October 6, 2016 (the Indenture) between JPL and The Bank of New York Mellon, London Branch as trustee, governing the Notes. Pursuant to the terms of the Indenture, the redemption price for the Notes will be equal to 102.43750% of the principal amount of such Notes, plus accrued and unpaid interest thereon, to (but not including) the Redemption Date (the Redemption Price). The Notes will be redeemed on a pro rata basis.

The above information is a part of company’s filings submitted to BSE.


 

Jubilant Pharmova Share Price

1076.40 7.20 (0.67%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×